Beta-Adrenergic Receptor Activation to Increase the Potency and Safety of Peripheral Blood Stem Cell Grafts
This technology features a method for altering immune cell composition of peripheral blood stem cell grafts in donors or patients prior to collection and transplantation to treat blood and immune deficiency diseases. The technology aims to alter immune cell subtypes in the graft to evoke increased graft-versus-tumor effects and reduce the incidence...
Published: 4/3/2023
|
Inventor(s): Richard Simpson, Emmanuel Katsanis, Richard Bond
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Blood & Lymphatic Disease, Technology Classifications > Healthcare Portfolios > Transplantation
|